Sciety

🎉 Nobel Day: celebrating discoveries that transform lives Today marks a special day, as the Nobel Prize ceremony honours groundbreaking discoveries that shape our understanding of science and medicine. At Sciety, we are inspired by how foundational research evolves into life-changing treatments and technologies. Partnering with Nordic life science companies, we witness firsthand how groundbreaking ideas turn into solutions that truly improve patients' lives. The achievements of this year's Nobel laureates inspire hope and remind us that every great discovery has the potential to transform lives and shape a brighter future for all! #nobelprize #lifescience #venturecapital

🏥 Another exciting step for our portfolio company Encare - Enhancing ERAS®! Encare is a healthtech company offering a SaaS solution designed to improve surgical outcomes. The software supports hospitals in implementing best practices throughout the entire care chain – from diagnosis and preparation to surgery and rehabilitation. Encare is now supporting Karolinska University Hospital as it expands its ERAS®️ (Enhanced Recovery After Surgery) implementation to include urology services. Through Encare's innovative platform EIAS (ERAS®️ Interactive Audit System), more clinical teams at Karolinska can now systematically track and analyse treatment outcomes. By providing comprehensive insights into surgical processes and compliance with the latest evidence-based protocols, EIAS is supporting continuous improvement in patient care. “We’re proud to contribute with EIAS, empowering clinical teams to deliver even better outcomes and patient experiences. This aligns perfectly with our vision of driving progress in evidence-based care,” says Rasmus Waller, CEO of Encare. At Sciety, we’re inspired by Encare’s dedication to advancing surgical care standards and look forward to seeing their continued impact! #lifescience #healthtech #venturecapital

🗞️ Hot off the press! In our latest newsletter, we analyse key trends from FDA's recent drug approvals, including breakthroughs in gene editing, precision medicine, and cell therapy for solid tumours. We also acknowledge Sciety's 10-year journey in the Nordic life science ecosystem and share a fascinating breakthrough in complete brain mapping. Plus, exciting updates from some of our portfolio companies: Predicare AB, NEOGAP Therapeutics AB, Capitainer, and Elypta. Read the full newsletter to stay up-to-date on the latest updates from Sciety and the life science ecosystem. #LifeScience #Innovation #Healthcare #NordicInnovation

🗞️ Hot off the press! In our latest newsletter, we analyse key trends from FDA's recent drug approvals, including breakthroughs in gene editing, precision medicine, and cell therapy for solid tumours. We also acknowledge Sciety's 10-year journey in the Nordic life science ecosystem and share a fascinating breakthrough in complete brain mapping. Plus, exciting updates from some of our portfolio companies: Predicare AB, NEOGAP Therapeutics AB, Capitainer, and Elypta. Read the full newsletter to stay up-to-date on the latest updates from Sciety and the life science ecosystem. #LifeScience #Innovation #Healthcare #NordicInnovation

🔬 The rapid advancement of AI is expected to significantly transform healthcare, and implementation is gaining momentum. A recent McKinsey survey reveals that more than 70% of participants from healthcare organisations have either already implemented or are implementing generative AI-based solutions. The greatest potential value lies in clinician and care provider productivity, specifically: ➡️ Improving speed and reliability of diagnosis ➡️ Enhanced treatment planning ➡️ Efficient care flows ➡️ Better forecasting of patient influx At Sciety, we encounter many Nordic companies leveraging generative AI in products and services aimed at improving healthcare efficiency. We meet companies using AI in products for patient risk stratification to ensure appropriate treatment interventions and predict the most suitable treatment for each patient, as well as solutions focused on optimising healthcare processes and operations management. The global AI in healthcare market size was estimated at USD 19 billion in 2023 and is expected to grow at an annual rate of 38.5% through 2030. 💡 Want to receive life science insights like these straight to your inbox? Sign up for Sciety's newsletter to receive news, exclusive event invitations and updates about upcoming investment opportunities: https://lnkd.in/dmWn7y4s #HealthcareInnovation #AI #NordicHealthTech

🎉 Celebrating a decade in Nordic life science! On this day 10 years ago, Sciety was officially registered as a company. For the past decade, we've had the privilege of working alongside remarkable scientists and entrepreneurs who are advancing healthcare through innovations in life science and digital health. Our journey so far: ✅ Over 1 billion SEK invested ✅ 26 innovative portfolio companies ✅ 9 successful exits through acquisitions or IPOs ✅ Countless life science innovations being developed into impactful solutions Thank you to all our partners, investors, portfolio companies and team members who have contributed to developing the Nordic life science ecosystem together with us over the past decade ⭐️ Read more about our journey and upcoming plans in our latest article: https://lnkd.in/gcnt_7tE #LifeScience #HealthTech #VentureCapital

🔬Another big step forward for our portfolio company NEOGAP Therapeutics AB! Neogap Therapeutics - developing personalised cancer immunotherapy using the patient's own cells - has entered a strategic manufacturing partnership with the CDMO NorthX Biologics. The partnership focuses on optimising and scaling production of Neogap's personalized pTTL therapy, currently in a Phase I/II clinical trial assessing safety and tolerability in patients with advanced colorectal cancer. By combining Neogap's innovative approach with NorthX Biologics' manufacturing expertise, this collaboration aims to establish a cost-effective and scalable production setup that will support both future large-scale clinical trials and broader patient access. The collaboration is supported by the European Innovation Council (EIC) Accelerator and marks an important step in Neogap's journey. Congratulations team Neogap on this significant milestone!  #LifeScience #Immunotherapy #VentureCapital

🚀 Exciting news from our portfolio company Capitainer! Capitainer has just launched the innovative Capitainer®SEP10 sampling card, designed for easy and reliable at-home blood sampling. Capitainer®SEP10 is revolutionising diagnostics and research with a streamlined sampling process: ✅ Measurement of exact blood volume ✅ Separation of blood cells from the liquid ✅ No need for a trained phlebotomist ✅ Indication of sample success ✅ No need for syringes, gloves, or specialized equipment Capitainer®SEP10 is now ready to impact healthcare diagnostics across the U.S. and EU. This cutting-edge tool has already drawn the attention of the research community, including Professor Henrik Zetterberg, who calls it a game-changer for neurodegenerative disease diagnostics. Congratulations to Capitainer on this remarkable launch! We look forward to seeing the positive impact of this new technology. #LifeScience #HealthcareInnovation #Diagnostics #MedTech 

👋 Meet us at BIO-Europe 4-6 November! We're looking forward to attending BIO-Europe in Stockholm next week. Andreas Lindblom, Marcus Hjort, MD, PhD, Nick Roelofs, and Tor Sander will be there to connect with interesting life science companies and other investors within life science.    Drop us a message or reach out through the partnering portal to schedule a meeting - we would be happy to connect!   #BIOEurope #lifescience #venturecapital

🍁 Autumn is officially here and with that comes a fresh edition of our newsletter Sciety News & Insights. This month we explore the rapid adoption of generative AI in healthcare and the potential it holds for improving patient outcomes and operational efficiency. Additionally, we take a closer look at the groundbreaking discovery of microRNA, which was recognised with this year's Nobel Prize in Physiology or Medicine. We also share the latest updates from some of our portfolio companies: Akiram Therapeutics, Elypta, Capitainer, Encare - Enhancing ERAS®, NEOGAP Therapeutics AB, and Synartro.   Read the full newsletter to stay up-to-date on the latest updates from Sciety and the life science ecosystem.